Agersų, H <br/><br/>
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Feb 2011 
 - 333-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/j.1538-7836.2010.04152.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens--blood<br/>Antithrombins--administration & dosage<br/>Factor VIIa--immunology<br/>Hemophilia A--drug therapy<br/>Humans<br/>Immunoenzyme Techniques<br/>Infusions, Intravenous<br/>Recombinant Proteins--pharmacokinetics